Cargando…

Higher risk of stent thrombosis with double therapy with direct oral anticoagulants: cherry picking the populations of interest does not help

Detalles Bibliográficos
Autores principales:	Gargiulo, Giuseppe, Goette, Andreas, Vranckx, Pascal, Valgimigli, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Discussion Forum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194183/ https://www.ncbi.nlm.nih.gov/pubmed/32060541 http://dx.doi.org/10.1093/eurheartj/ehaa076

Ejemplares similares

Drug–drug interaction between levetiracetam and non-vitamin K antagonist anticoagulants
por: Mathy, François-Xavier, et al.
Publicado: (2019)

Left main bifurcation treatment: is one stent enough?
por: den Dekker, W K, et al.
Publicado: (2022)

Levetiracetam and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and epilepsy: a reasonable combination
por: von Oertzen, Tim J, et al.
Publicado: (2019)

Clinical and conceptual approaches to interpreting the findings of systematic review and meta-analysis of mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease
por: Jayaraj, Rama, et al.
Publicado: (2020)

How do Regulatory T Cells Work?
por: Corthay, A
Publicado: (2009)

A Conversation with Cohn on the Activation of CD4 T Cells
por: Bretscher, P. A.
Publicado: (2015)

On the Mechanism Determining the Th1/Th2 Phenotype of an Immune Response, and its Pertinence to Strategies for the Prevention, and Treatment, of Certain Infectious Diseases
por: Bretscher, P A
Publicado: (2014)

The Activation and Inactivation of Mature CD4 T cells: A Case for Peripheral Self–Nonself Discrimination
por: Bretscher, P A
Publicado: (2014)

Early hearing detection and intervention: Reflections from the South African context
por: Kanji, Amisha
Publicado: (2018)

Use of droxidopa for the long-term treatment of neurogenic orthostatic hypotension
por: Raj, Satish R, et al.
Publicado: (2019)

What to do with the equipoise?
por: Knol, Wiebe G, et al.
Publicado: (2019)

STAR evidence evaluation of viral fulminant myocarditis: Specificity, Timeliness, Accessibility, Risk
por: Wang, Si, et al.
Publicado: (2020)

Glucocorticoid and immunoglobulin to treat viral fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

Consideration on pathogen of viral fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

Men more vulnerable to COVID-19: explained by ACE2 on the X chromosome?
por: Sama, Iziah E, et al.
Publicado: (2020)

Extracorporeal cardiopulmonary resuscitation in out-of-hospital cardiac arrest in relation to organ donation
por: Roest, Stefan, et al.
Publicado: (2020)

Circulating plasma angiotensin-converting enzyme 2 concentration is elevated in patients with kidney disease and diabetes
por: Sama, Iziah E, et al.
Publicado: (2020)

Molecular model linking Th2 polarized M2 tumour‐associated macrophages with deaminase‐mediated cancer progression mutation signatures
por: Mamrot, Jared, et al.
Publicado: (2019)

Society and the reception of imaging technology: The American experience
por: Moreno, Jonathan
Publicado: (2011)

Regulatory T cells and co‐evolution of allele‐specific MHC recognition by the TCR
por: Steele, Edward J., et al.
Publicado: (2019)

Immune-mediated mechanism in coronavirus fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

Incident heart failure risk after bariatric surgery: the role of epicardial fat
por: van Woerden, Gijs, et al.
Publicado: (2020)

Periprocedural myocardial injury in the EXCEL trial
por: Bjørnstad, Johannes L, et al.
Publicado: (2020)

Fulminant myocarditis in the time of coronavirus
por: Cuomo, Vittoria, et al.
Publicado: (2020)

Acrolein exposure from electronic cigarettes
por: Mayer, Bernd
Publicado: (2020)

The role of implantable cardioverter-defibrillators in New York Heart Class I heart failure patients: do not abandon the asymptomatic just yet
por: van der Lingen, Anne-Lotte C J, et al.
Publicado: (2020)

Increased absorption of phytosterols is the simplest and most plausible explanation for coronary artery disease risk not accounted for by non-HDL cholesterol in high cholesterol absorbers
por: Helgadottir, Anna, et al.
Publicado: (2020)

Handling time elements for in-hospital cardiac arrest
por: Sultanian, Pedram, et al.
Publicado: (2021)

Oromucosal immunomodulation as clinical spectrum mitigating factor in SARS‐CoV‐2 infection
por: Rodríguez‐Argente, Francisco, et al.
Publicado: (2020)

Increase use of β-blockers in patients with chronic obstructive pulmonary and cardiovascular disease
por: Yang, Yan-Li, et al.
Publicado: (2021)

Early humoral defence: Contributing to confining COVID‐19 to conducting airways?
por: Persson, Carl
Publicado: (2021)

Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value
por: Pappone, Carlo, et al.
Publicado: (2021)

Big cohort studies offer insights into preventable risk factors
por: Wartolowska, Karolina Agnieszka, et al.
Publicado: (2021)

The Janus of COVID-19: from registry data to prospective studies
por: Sykes, Robert, et al.
Publicado: (2021)

Investigating the disease is the key to the obesity stigma
por: Rayner, Jennifer J, et al.
Publicado: (2021)

Myocardial infarction after elective percutaneous coronary intervention—which cardiac troponin cut-off to use?
por: Eggers, Kai M, et al.
Publicado: (2021)

A sex-specific prediction model is not enough to achieve equality for women in preventative cardiovascular medicine
por: Kimenai, Dorien M., et al.
Publicado: (2021)

Alcohol and atrial fibrillation: dose matters, not so much the type
por: Csengeri, Dora, et al.
Publicado: (2021)

The reduction in cardiovascular risk in REDUCE-IT is due to eicosapentaenoic acid in icosapent ethyl
por: Steg, Ph Gabriel, et al.
Publicado: (2021)

Dealing with the COVID-19 pandemic: an opportunity to reflect on sustainability research: May 29 2022
por: Nölting, Benjamin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2b9c2mvp0gk5qto5r9m4cjhe7s